{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T20:03:02Z","timestamp":1780948982497,"version":"3.54.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ministry of Health of Iran","award":["973382"],"award-info":[{"award-number":["973382"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Ment Health Addiction"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s11469-022-00992-x","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T19:02:52Z","timestamp":1672167772000},"page":"2378-2390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Characterizing People Who Inject Drugs with no History of Opioid Agonist Therapy Uptake in Iran: Results from a National Bio-behavioural Surveillance Survey in 2020"],"prefix":"10.1007","volume":"22","author":[{"given":"Fatemeh","family":"Mehrabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheil","family":"Mehmandoost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mirzazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Noroozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Tavakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Khezri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazal","family":"Mousavian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Ghalekhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvin","family":"Afsar Kazerooni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Navaiian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Farajzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Shokoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5631-4469","authenticated-orcid":false,"given":"Mohammad","family":"Karamouzian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,27]]},"reference":[{"issue":"10","key":"992_CR1","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1111\/add.13453","volume":"111","author":"M Amin-Esmaeili","year":"2016","unstructured":"Amin-Esmaeili, M., Rahimi-Movaghar, A., Sharifi, V., Hajebi, A., Radgoodarzi, R., Mojtabai, R., Hefazi, M., & Motevalian, A. (2016). Epidemiology of illicit drug use disorders in Iran: Prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey. Addiction, 111(10), 1836\u20131847. https:\/\/doi.org\/10.1111\/add.13453","journal-title":"Addiction"},{"issue":"1","key":"992_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-019-0842-5","volume":"19","author":"L Avery","year":"2019","unstructured":"Avery, L., Rotondi, N., McKnight, C., Firestone, M., Smylie, J., & Rotondi, M. (2019). Unweighted regression models perform better than weighted regression techniques for respondent-driven sampling data: Results from a simulation study. BMC Medical Research Methodology, 19(1), 1\u201313. https:\/\/doi.org\/10.1186\/s12874-019-0842-5","journal-title":"BMC Medical Research Methodology"},{"issue":"4","key":"992_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/acps.13088","volume":"140","author":"A Bahji","year":"2019","unstructured":"Bahji, A., Cheng, B., Gray, S., & Stuart, H. (2019). Reduction in mortality risk with opioid agonist therapy: A systematic review and meta-analysis. The Acta Psychiatrica Scandinavica, 140(4), 313\u2013339. https:\/\/doi.org\/10.1111\/acps.13088","journal-title":"The Acta Psychiatrica Scandinavica"},{"issue":"7","key":"992_CR4","doi-asserted-by":"publisher","first-page":"e96311","DOI":"10.5812\/semj.96311","volume":"21","author":"M Dehghan","year":"2020","unstructured":"Dehghan, M., Shokoohi, M., Mokhtarabadi, S., Tavakoli, F., Iranpour, A., Rad, A. A. R., Nasiri, N., Karamouzian, M., & Sharifi, H. (2020). HIV-related knowledge and stigma among the general population in the southeast of Iran. Shiraz E Medical Journal, 21(7), e96311. https:\/\/doi.org\/10.5812\/semj.96311","journal-title":"Shiraz E Medical Journal"},{"issue":"11","key":"992_CR5","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1089\/jwh.2010.2694","volume":"20","author":"K Dolan","year":"2011","unstructured":"Dolan, K., Salimi, S., Nassirimanesh, B., Mohsenifar, S., Allsop, D., & Mokri, A. (2011). Characteristics of Iranian women seeking drug treatment. Journal of Women\u2019s Health, 20(11), 1687\u20131691. https:\/\/doi.org\/10.1089\/jwh.2010.2694","journal-title":"Journal of Women's Health"},{"issue":"6","key":"992_CR6","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s11469-018-9930-8","volume":"17","author":"VA Earnshaw","year":"2019","unstructured":"Earnshaw, V. A., Bogart, L. M., Menino, D. D., Kelly, J. F., Chaudoir, S. R., Reed, N. M., & Levy, S. (2019). Disclosure, stigma, and social support among young people receiving treatment for substance use disorders and their caregivers: A qualitative analysis. International Journal of Mental Health and Addiction, 17(6), 1535\u20131549. https:\/\/doi.org\/10.1007\/s11469-018-9930-8","journal-title":"International Journal of Mental Health and Addiction"},{"key":"992_CR7","doi-asserted-by":"publisher","unstructured":"Ekhtiari H, N. A., Farhoudian A, Radfar SR, Hajebi A, Sefatian S, Zare-Bidoky M, Razaghi EM, Mokri A, Rahimi-Movaghar A, Rawson R. (2020). The evolution of addiction treatment and harm reduction programs in Iran: A chaotic response or a synergistic diversity. Addiction, 115(7), 1395\u20131403. https:\/\/doi.org\/10.1111\/add.14905.","DOI":"10.1111\/add.14905"},{"key":"992_CR8","doi-asserted-by":"publisher","unstructured":"El-Bassel, N., & Strathdee, S. A. (2015). Women who use or inject drugs: An action agenda for women-specific, multilevel and combination HIV prevention and research. Journal of Acquired Immune Deficiency Syndromes (1999), 69(Suppl 2), S182. https:\/\/doi.org\/10.1097\/QAI.0000000000000628.","DOI":"10.1097\/QAI.0000000000000628"},{"key":"992_CR9","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1007\/s11469-020-00439-1","volume":"20","author":"SH Faghihi","year":"2022","unstructured":"Faghihi, S. H., Ghalekhani, N., Kazerooni, P. A., & Nasirian, M. (2022). Size estimation of people who inject drugs and their geographical distribution in dogonbadan, Iran, during 2018: A mapping method. International Journal of Mental Health and Addiction, 20, 1246\u20131258. https:\/\/doi.org\/10.1007\/s11469-020-00439-1","journal-title":"International Journal of Mental Health and Addiction"},{"key":"992_CR10","unstructured":"Farhoudian, A., Sadeghi, M., Khoddami Vishteh, H. R., Moazen, B., Fekri, M., & Rahimi Movaghar, A. (2014). Component analysis of Iranian crack; a newly abused narcotic substance in Iran. Iranian journal of pharmaceutical research, 13(1), 337\u2013344. https:\/\/pubmed.ncbi.nlm.nih.gov\/24734089\/."},{"issue":"7","key":"992_CR11","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1111\/add.15316","volume":"116","author":"CF Ferraro","year":"2021","unstructured":"Ferraro, C. F., Stewart, D. E., Grebely, J., Tran, L. T., Zhou, S., Puca, C., Hajarizadeh, B., Larney, S., Santo, T., Jr., & Higgins, J. P. (2021). Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: A systematic review and meta-analysis. Addiction, 116(7), 1664\u20131676. https:\/\/doi.org\/10.1111\/add.15316","journal-title":"Addiction"},{"key":"992_CR12","doi-asserted-by":"publisher","first-page":"102981","DOI":"10.1016\/j.drugpo.2020.102981","volume":"87","author":"J Friedman","year":"2021","unstructured":"Friedman, J., Syvertsen, J. L., Bourgois, P., Bui, A., Beletsky, L., & Pollini, R. (2021). Intersectional structural vulnerability to abusive policing among people who inject drugs: A mixed methods assessment in California\u2019s central Valley. International Journal of Drug Policy, 87, 102981. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102981","journal-title":"International Journal of Drug Policy"},{"issue":"7","key":"992_CR13","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1016\/S2468-2667(19)30060-X","volume":"4","author":"N Gisev","year":"2019","unstructured":"Gisev, N., Bharat, C., Larney, S., Dobbins, T., Weatherburn, D., Hickman, M., Farrell, M., & Degenhardt, L. (2019). The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: A retrospective cohort study. The Lancet Public Health, 4(7), e334\u2013e342. https:\/\/doi.org\/10.1016\/S2468-2667(19)30060-X","journal-title":"The Lancet Public Health"},{"issue":"1","key":"992_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13722-018-0116-2","volume":"13","author":"SE Hadland","year":"2018","unstructured":"Hadland, S. E., Park, T. W., & Bagley, S. M. (2018). Stigma associated with medication treatment for young adults with opioid use disorder: A case series. Addiction Science & Clinical Practice, 13(1), 15. https:\/\/doi.org\/10.1186\/s13722-018-0116-2","journal-title":"Addiction Science & Clinical Practice"},{"issue":"2","key":"992_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2307\/3096941","volume":"44","author":"DD Heckathorn","year":"1997","unstructured":"Heckathorn, D. D. (1997). Respondent-driven sampling: A new approach to the study of hidden populations. Social Problems, 44(2), 174\u2013199. https:\/\/doi.org\/10.2307\/3096941","journal-title":"Social Problems"},{"key":"992_CR16","doi-asserted-by":"publisher","unstructured":"Hesam, S., Honarvar, N., & Vahdat, S. (2014). The analysis of cost-effectiveness of methadone and buprenorphine maintenance treatment for preventing HIV infection in drug-injection users (a case study: the selected withdrawal centers under the supervision of Shiraz University of Medical Sciences). Journal of Health Accounting, 3(3), 18\u201339. https:\/\/doi.org\/10.30476\/jha.2014.16991.","DOI":"10.30476\/jha.2014.16991"},{"key":"992_CR17","unstructured":"Global Strategic Information. (2014). Toolbox for conducting integrated HIV bio-behavioral surveillance (IBBS) in key populations: PWID questionnaire. Retrieved November 30, 2022 from https:\/\/globalhealthsciences.ucsf.edu\/sites\/globalhealthsciences.ucsf.edu\/files\/ibbs-intro.pdf."},{"key":"992_CR18","doi-asserted-by":"publisher","first-page":"103584","DOI":"10.1016\/j.drugpo.2022.103584","volume":"102","author":"M Karamouzian","year":"2022","unstructured":"Karamouzian, M., Pilarinos, A., Hayashi, K., Buxton, J. A., & Kerr, T. (2022). Latent patterns of polysubstance use among people who use opioids: A systematic review. International Journal of Drug Policy, 102, 103584. https:\/\/doi.org\/10.1016\/j.drugpo.2022.103584","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"992_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12939-018-0787-z","volume":"17","author":"M Khazaee-Pool","year":"2018","unstructured":"Khazaee-Pool, M., Moeeni, M., Ponnet, K., Fallahi, A., Jahangiri, L., & Pashaei, T. (2018). Perceived barriers to methadone maintenance treatment among Iranian opioid users. International Journal for Equity in Health, 17(1), 1\u201310. https:\/\/doi.org\/10.1186\/s12939-018-0787-z","journal-title":"International Journal for Equity in Health"},{"key":"992_CR20","doi-asserted-by":"publisher","first-page":"103355","DOI":"10.1016\/j.drugpo.2021.103355","volume":"97","author":"M Khezri","year":"2021","unstructured":"Khezri, M., Karamouzian, M., Sharifi, H., Ghalekhani, N., Tavakoli, F., Mehmandoost, S., Mehrabi, F., Pedarzadeh, M., Nejat, M., & Noroozi, A. (2021). Willingness to utilize supervised injection facilities among people who inject drugs in Iran: Findings from 2020 national HIV bio-behavioral surveillance survey. International Journal of Drug Policy, 97, 103355. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103355","journal-title":"International Journal of Drug Policy"},{"key":"992_CR21","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1007\/s10461-022-03627-3","volume":"26","author":"M Khezri","year":"2022","unstructured":"Khezri, M., Shokoohi, M., Mirzazadeh, A., Tavakoli, F., Ghalekhani, N., Mousavian, G., Mehmandoost, S., Kazerooni, P. A., Haghdoost, A. A., Karamouzian, M., & Sharifi, H. (2022). HIV prevalence and related behaviors among people who inject drugs in Iran from 2010 to 2020. AIDS and Behavior, 26, 2831\u20132843. https:\/\/doi.org\/10.1007\/s10461-022-03627-3","journal-title":"AIDS and Behavior"},{"issue":"1","key":"992_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1360-0443.2011.03601.x","volume":"107","author":"JD Livingston","year":"2012","unstructured":"Livingston, J. D., Milne, T., Fang, M. L., & Amari, E. (2012). The effectiveness of interventions for reducing stigma related to substance use disorders: A systematic review. Addiction, 107(1), 39\u201350. https:\/\/doi.org\/10.1111\/j.1360-0443.2011.03601.x","journal-title":"Addiction"},{"issue":"8","key":"992_CR23","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/add.13779","volume":"112","author":"J Marsden","year":"2017","unstructured":"Marsden, J., Stillwell, G., Jones, H., Cooper, A., Eastwood, B., Farrell, M., Lowden, T., Maddalena, N., Metcalfe, C., & Shaw, J. (2017). Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England. Addiction, 112(8), 1408\u20131418. https:\/\/doi.org\/10.1111\/add.13779","journal-title":"Addiction"},{"key":"992_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijid.2016.03.022","volume":"46","author":"LB Mlunde","year":"2016","unstructured":"Mlunde, L. B., Sunguya, B. F., Mbwambo, J. K. K., Ubuguyu, O. S., Yasuoka, J., & Jimba, M. (2016). Association of opioid agonist therapy with the initiation of antiretroviral therapy-a systematic review. International Journal of Infectious Diseases, 46, 27\u201333. https:\/\/doi.org\/10.1016\/j.ijid.2016.03.022","journal-title":"International Journal of Infectious Diseases"},{"issue":"3","key":"992_CR25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1080\/00952990.2021.1887202","volume":"47","author":"E Moazen-Zadeh","year":"2021","unstructured":"Moazen-Zadeh, E., Ziafat, K., Yazdani, K., Kamel, M. M., Wong, J. S. H., Modabbernia, A., Blanken, P., Verthein, U., Sch\u00fctz, C. G., Jang, K., Akhondzadeh, S., & Krausz, R. M. (2021). Impact of opioid agonist treatment on mental health in patients with opioid use disorder: A systematic review and network meta-analysis of randomized clinical trials. American Journal of Drug and Alcohol Abuse, 47(3), 280\u2013304. https:\/\/doi.org\/10.1080\/00952990.2021.1887202","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"992_CR26","doi-asserted-by":"publisher","unstructured":"Mohebbi, E., Haghdoost, A. A., Noroozi, A., Vardanjani, H. M., Hajebi, A., Nikbakht, R., Mehrabi, M., Kermani, A. J., Salemianpour, M., & Baneshi, M. R. (2019). Awareness and attitude towards opioid and stimulant use and lifetime prevalence of the drugs: A study in 5 large cities of Iran. International Journal of Health Policy and Management, 8(4), 222. https:\/\/doi.org\/10.15171\/ijhpm.2018.128.","DOI":"10.15171\/ijhpm.2018.128"},{"key":"992_CR27","doi-asserted-by":"publisher","unstructured":"Momtazi, S., Noroozi, A., & Rawson, R. (2015). An overview of Iran drug treatment and harm reduction programs. Textbook of addiction treatment: International perspectives. Springer, 543\u2013554. https:\/\/doi.org\/10.1007\/978-88-470-5322-9_25.","DOI":"10.1007\/978-88-470-5322-9_25"},{"key":"992_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.addbeh.2016.02.020","volume":"58","author":"J Montain","year":"2016","unstructured":"Montain, J., Ti, L., Hayashi, K., Nguyen, P., Wood, E., & Kerr, T. (2016). Impact of length of injecting career on HIV incidence among people who inject drugs. Addictive Behavior, 58, 90\u201394. https:\/\/doi.org\/10.1016\/j.addbeh.2016.02.020","journal-title":"Addictive Behavior"},{"issue":"1","key":"992_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-020-00392-1","volume":"17","author":"M Nakhaeizadeh","year":"2020","unstructured":"Nakhaeizadeh, M., Abdolahinia, Z., Sharifi, H., Mirzazadeh, A., Haghdoost, A. A., Shokoohi, M., Baral, S., Karamouzian, M., & Shahesmaeili, A. (2020). Opioid agonist therapy uptake among people who inject drugs: The findings of two consecutive bio-behavioral surveillance surveys in Iran. Harm Reduction Journal, 17(1), 1\u20138. https:\/\/doi.org\/10.1186\/s12954-020-00392-1","journal-title":"Harm Reduction Journal"},{"key":"992_CR30","doi-asserted-by":"publisher","unstructured":"Nielsen, S., Larance, B., Degenhardt, L., Gowing, L., Kehler, C., & Lintzeris, N. (2016). Opioid agonist treatment for pharmaceutical opioid dependent people. The Cochrane Database of Systematic Reviews (5), Cd011117. https:\/\/doi.org\/10.1002\/14651858.CD011117.pub2.","DOI":"10.1002\/14651858.CD011117.pub2"},{"key":"992_CR31","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.drugpo.2016.01.013","volume":"31","author":"A Nikfarjam","year":"2016","unstructured":"Nikfarjam, A., Shokoohi, M., Shahesmaeili, A., Haghdoost, A. A., Baneshi, M. R., Haji-Maghsoudi, S., Rastegari, A., Nasehi, A. A., Memaryan, N., & Tarjoman, T. (2016). National population size estimation of illicit drug users through the network scale-up method in 2013 in Iran. International Journal of Drug Policy, 31, 147\u2013152. https:\/\/doi.org\/10.1016\/j.drugpo.2016.01.013","journal-title":"International Journal of Drug Policy"},{"issue":"3","key":"992_CR32","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1001\/jamapediatrics.2021.4606","volume":"176","author":"A Pilarinos","year":"2021","unstructured":"Pilarinos, A., Bromberg, D. J., & Karamouzian, M. (2021). Access to medications for opioid use disorder and associated factors among adolescents and young adults: A systematic review. JAMA Pediatrics, 176(3), 304\u2013311. https:\/\/doi.org\/10.1001\/jamapediatrics.2021.4606","journal-title":"JAMA Pediatrics"},{"issue":"4","key":"992_CR33","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/add.14853","volume":"115","author":"Y Rahimi","year":"2020","unstructured":"Rahimi, Y., Gholami, J., Amin-Esmaeili, M., Fotouhi, A., Rafiemanesh, H., Shadloo, B., & Rahimi-Movaghar, A. (2020). HIV prevalence among people who inject drugs (PWID) and related factors in Iran: A systematic review, meta-analysis and trend analysis. Addiction, 115(4), 605\u2013622. https:\/\/doi.org\/10.1111\/add.14853","journal-title":"Addiction"},{"issue":"1","key":"992_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-020-00441-9","volume":"18","author":"A Rajabi","year":"2021","unstructured":"Rajabi, A., Sharafi, H., & Alavian, S. M. (2021). Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: An updated systematic review and cumulative meta-analysis. Harm Reduction Journal, 18(1), 1\u201325. https:\/\/doi.org\/10.1186\/s12954-020-00441-9","journal-title":"Harm Reduction Journal"},{"key":"992_CR35","doi-asserted-by":"publisher","unstructured":"Rastegari, A., Baneshi, M. R., Hajebi, A., Haghdoost, A. A., Sharifi, H., Noroozi, A., Karamouzian, M., Shokoohi, M., Mirzazadeh, A., & Haji Maghsoudi, S. (2022). Population size estimation of people using illicit drugs and alcohol in Iran (2015\u20132016). International journal of health policy and management. https:\/\/doi.org\/10.34172\/ijhpm.2022.6578.","DOI":"10.34172\/ijhpm.2022.6578"},{"issue":"2","key":"992_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0955-3959(02)00007-5","volume":"13","author":"T Rhodes","year":"2002","unstructured":"Rhodes, T. (2002). The \u2018risk environment\u2019: A framework for understanding and reducing drug-related harm. International Journal of Drug Policy, 13(2), 85\u201394. https:\/\/doi.org\/10.1016\/S0955-3959(02)00007-5","journal-title":"International Journal of Drug Policy"},{"key":"992_CR37","doi-asserted-by":"publisher","unstructured":"Rhodes, T. (2009). Risk environments and drug harms: A social science for harm reduction approach. International Journal of Drug Policy, 20(3):193\u2013201. https:\/\/doi.org\/10.1016\/j.drugpo.2008.10.003.","DOI":"10.1016\/j.drugpo.2008.10.003"},{"key":"992_CR38","unstructured":"Roshanfekr, P., Farnia, M., & Dejman, M. (2013). The effectiveness of harm reduction programs in seven prisons of Iran. Iranian Journal of Public Health, 42(12), 1430\u20131437. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4441940\/."},{"key":"992_CR39","doi-asserted-by":"publisher","unstructured":"Saberi Zafarghandi, M. B., Eshrati, S., Arezoomandan, R., Farnia, M., Mohammadi, H., Vahed, N., Javaheri, A., Amini, M., & Heidari, S. (2021). Review, documentation, assessment of treatment, and harm reduction programs of substance use disorder in Iranian Prisons. Iranian Journal of Public Health, 27(1), 48\u201363. https:\/\/doi.org\/10.32598\/ijpcp.27.1.3324.1.","DOI":"10.32598\/ijpcp.27.1.3324.1"},{"key":"992_CR40","doi-asserted-by":"publisher","first-page":"108419","DOI":"10.1016\/j.drugalcdep.2020.108419","volume":"218","author":"HT Saleem","year":"2021","unstructured":"Saleem, H. T., Likindikoki, S., Nonyane, B. A., Nkya, I. H., Zhang, L., Mbwambo, J., & Latkin, C. (2021). Correlates of non-fatal, opioid overdose among women who use opioids in Dar es Salaam, Tanzania. Drug and Alcohol Dependence, 218, 108419. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108419","journal-title":"Drug and Alcohol Dependence"},{"key":"992_CR41","doi-asserted-by":"publisher","unstructured":"Sattler, S., Zolala, F., Baneshi, M. R., Ghasemi, J., & Amirzadeh Googhari, S. (2021). Public stigma toward female and male opium and heroin users. An experimental test of attribution theory and the familiarity hypothesis. Frontiers in Public Health, 9, 652876. https:\/\/doi.org\/10.3389\/fpubh.2021.652876.","DOI":"10.3389\/fpubh.2021.652876"},{"issue":"1","key":"992_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-020-00429-5","volume":"17","author":"S Shirley-Beavan","year":"2020","unstructured":"Shirley-Beavan, S., Roig, A., Burke-Shyne, N., Daniels, C., & Csak, R. (2020). Women and barriers to harm reduction services: A literature review and initial findings from a qualitative study in Barcelona, Spain. Harm Reduction Journal, 17(1), 1\u201313. https:\/\/doi.org\/10.1186\/s12954-020-00429-5","journal-title":"Harm Reduction Journal"},{"issue":"9737","key":"992_CR43","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S0140-6736(10)60743-X","volume":"376","author":"SA Strathdee","year":"2010","unstructured":"Strathdee, S. A., Hallett, T. B., Bobrova, N., Rhodes, T., Booth, R., Abdool, R., & Hankins, C. A. (2010). HIV and risk environment for injecting drug users: The past, present, and future. The Lancet, 376(9737), 268\u2013284. https:\/\/doi.org\/10.1016\/S0140-6736(10)60743-X","journal-title":"The Lancet"},{"key":"992_CR44","doi-asserted-by":"publisher","first-page":"108655","DOI":"10.1016\/j.drugalcdep.2021.108655","volume":"221","author":"F Tavakoli","year":"2021","unstructured":"Tavakoli, F., Khezri, M., Tam, M., Bazrafshan, A., Sharifi, H., & Shokoohi, M. (2021). Injection and non-injection drug use among female sex workers in Iran: A systematic review and meta-analysis. Drug and Alcohol Dependence, 221, 108655. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108655","journal-title":"Drug and Alcohol Dependence"},{"key":"992_CR45","doi-asserted-by":"crossref","unstructured":"Topp, L., Iversen, J., Conroy, A., Salmon, A. M., Maher, L., & NSPs, C. o. A. (2008). Prevalence and predictors of injecting-related injury and disease among clients of Australia's needle and syringe programs. Australian and New Zealand Journal of Public Health, 32(1), 34-37.","DOI":"10.1111\/j.1753-6405.2008.00163.x"},{"issue":"5","key":"992_CR46","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4103\/sja.sja_203_17","volume":"11","author":"S Tsang","year":"2017","unstructured":"Tsang, S., Royse, C., & Terkawi, A. (2017). Guidelines for developing, translating, and validating a questionnaire in perioperative and pain medicine. Saudi Journal of Anaesthesia, 11(5), 80. https:\/\/doi.org\/10.4103\/sja.sja_203_17","journal-title":"Saudi Journal of Anaesthesia"},{"key":"992_CR47","unstructured":"UNAIDS. (2022). Global AIDS Monitoring 2022. Retrieved November 25, 2022 from https:\/\/www.unaids.org\/en\/resources\/documents\/2022\/global-aids-monitoring-guidelines."},{"issue":"11","key":"992_CR48","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1111\/add.15503","volume":"116","author":"DK Van Santen","year":"2021","unstructured":"Van Santen, D. K., Boyd, A., Matser, A., Maher, L., Hickman, M., Lodi, S., & Prins, M. (2021). The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: Findings from an emulated target trial. Addiction, 116(11), 3115\u20133126. https:\/\/doi.org\/10.1111\/add.15503","journal-title":"Addiction"},{"issue":"2","key":"992_CR49","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1016\/S2214-109X(16)30303-5","volume":"5","author":"MP Wegman","year":"2017","unstructured":"Wegman, M. P., Altice, F. L., Kaur, S., Rajandaran, V., Osornprasop, S., Wilson, D., Wilson, D. P., & Kamarulzaman, A. (2017). Relapse to opioid use in opioid-dependent individuals released from compulsory drug detention centres compared with those from voluntary methadone treatment centres in Malaysia: A two-arm, prospective observational study. The Lancet Global Health, 5(2), e198\u2013e207. https:\/\/doi.org\/10.1016\/S2214-109X(16)30303-5","journal-title":"The Lancet Global Health"},{"key":"992_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1178221816685","volume":"11","author":"J Woo","year":"2017","unstructured":"Woo, J., Bhalerao, A., Bawor, M., Bhatt, M., Dennis, B., Mouravska, N., Zielinski, L., & Samaan, Z. (2017). \u201cDon\u2019t judge a book by its cover\u201d: A qualitative study of methadone patients\u2019 experiences of stigma. Substance Abuse: Research and Treatment, 11, 1\u201312. https:\/\/doi.org\/10.1177\/1178221816685","journal-title":"Substance Abuse: Research and Treatment"},{"issue":"2","key":"992_CR51","doi-asserted-by":"publisher","first-page":"e22320","DOI":"10.5812\/ijhrba.22320","volume":"5","author":"F Zolala","year":"2016","unstructured":"Zolala, F., Mahdavian, M., Haghdoost, A. A., & Karamouzian, M. (2016). Pathways to addiction: A gender-based study on drug use in a triangular clinic and drop-in center, Kerman, Iran. International Journal of High-Risk Behaviors & Addiction, 5(2), e22320. https:\/\/doi.org\/10.5812\/ijhrba.22320","journal-title":"International Journal of High-Risk Behaviors & Addiction"}],"container-title":["International Journal of Mental Health and Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11469-022-00992-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11469-022-00992-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11469-022-00992-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T11:21:23Z","timestamp":1725362483000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11469-022-00992-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,27]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["992"],"URL":"https:\/\/doi.org\/10.1007\/s11469-022-00992-x","relation":{},"ISSN":["1557-1874","1557-1882"],"issn-type":[{"value":"1557-1874","type":"print"},{"value":"1557-1882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,27]]},"assertion":[{"value":"13 December 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Before starting the interview, participants were briefed about the study\u2019s objectives and procedures. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}